Approval also includes extending the Nucleus 7 Sound Processor to the first U.S. cochlear implant recipients, Custom Sound Pro fitting software to enhance support for hearing professionals LONE TREE, ...

Cochlear Limited, the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration (FDA) approval of three new products to its suite of hearing technology ...

Upgradeable Firmware: The Cochlear™ Nucleus ® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates.

The news: Hearing device maker Cochlear has received regulatory approval from the US Food and Drug Administration (FDA) for its new Nucleus Nexa System, and its Nucleus Kanso 3 and Kanso 3 Nexa sound ...

LONE TREE, Colo., July 6, 2020 /PRNewswire/ -- Cochlear Limited (ASX:COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration (FDA) approval of ...

* COCHLEAR OBTAINS FDA APPROVAL OF KANSO 2 SOUND PROCESSOR, FIRST OFF-THE-EAR COCHLEAR IMPLANT SOUND PROCESSOR WITH DIRECT SMARTPHONE CONNECTIVITY Sign up here. * COCHLEAR LTD - NEW PRODUCTS WILL BE ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...